Serialization Impact on Pharma Packaging OEE: What the 2025-2026 Data Actually Shows When the US DSCSA (Drug Supply Chain Security Act) and EU FMD (Falsified Medicines Directive) came into full enforcement during 2023-2024, the common industry concern was that...
How to Move from Median to Top Quartile Pharma Packaging OEE in 90 Days The gap between a median pharma packaging line at 56% OEE and a top-quartile line at 68% represents roughly $3.2-5.8M per year per line in recoverable production capacity for a typical mid-size...
Pharma OEE Benchmark 2026: Where Your Packaging Line Actually Stands Against the Industry Pharmaceutical packaging OEE is one of the most discussed and least accurately measured KPIs in the industry. Internal reports consistently show numbers in the 70-80% range,...
Downtime Reduction ROI: How to Build the Business Case That Survives CFO Scrutiny in 2026 When the operations team proposes a downtime reduction investment — IoT monitoring, predictive maintenance, process improvement — the ROI case typically follows a predictable...
The Hidden Cost of Micro-Stops Your MES Does Not See — And Why It Quietly Destroys OEE Most plants have a downtime reporting system. Some have a full MES with event logging, others have a homegrown Excel-plus-paper system, a few have nothing structured at all. All...
The True Cost of Manufacturing Downtime in 2026: A CFO-Grade Framework for Measuring What You’re Actually Losing When a plant manager says “we had two hours of downtime on Line 3 yesterday,” the follow-up question rarely asked — and rarely answered...
